Recombinant Human Von Hippel Lindau Tumor Suppressor (vHL), Unconjugated, E. coli

Artikelnummer: BIM-RPU56239
Artikelname: Recombinant Human Von Hippel Lindau Tumor Suppressor (vHL), Unconjugated, E. coli
Artikelnummer: BIM-RPU56239
Hersteller Artikelnummer: RPU56239
Alternativnummer: BIM-RPU56239-50UG,BIM-RPU56239-100UG,BIM-RPU56239-1MG
Hersteller: Biomatik Corporation
Wirt: E. coli
Kategorie: Proteine/Peptide
Applikation: Control, SDS-PAGE, WB
Spezies Reaktivität: Human
Konjugation: Unconjugated
Alternative Synonym: HRCA1, RCA1, VHL1, Von Hippel-Lindau Syndrome
Recombinant Human Von Hippel Lindau Tumor Suppressor (vHL) is a purified Prokaryotic Protein. Purity: >80% by SDS-PAGE. Host: E. coli. Endotoxin Level: <1.0EU per 1ug, by the LAL method. Species: Human (Homo sapiens). Target Name: Von Hippel Lindau Tumor Suppressor (vHL). Target Synonyms: HRCA1, RCA1, VHL1, Von Hippel-Lindau Syndrome. Accession Number: P40337. Gene ID: 7428. Expression Region: Met1~Asp213. Tag Info: N-terminal His Tag. Theoretical MW: 35kDa. Buffer: PBS, pH7.4, containing 0.01% SKL, 5% Trehalose. Storage: -20C. Avoid repeated freeze/thaw cycles. Restrictions: For Research Use Only. Not for use in diagnostic procedures.
Molekulargewicht: 35kDa
Tag: N-Terminal His Tag
NCBI: 7428
Puffer: PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
Expression System: Prokaryotic Expression
Reinheit: >80% by SDS-PAGE
Formulierung: Freeze-dried powder
Target-Kategorie: Von Hippel Lindau Tumor Suppressor (vHL)